This TLR4/Gal-1 signaling pathway further stimulates a disintegrin and metalloproteinase (ADAM) 10 and ADAM17, enhancing invasion activity and promoting the acquisition of mesenchymal characteristics in LPS-treated CRC cells. The gene discussed is TLR4; the disease is colorectal carcinoma.